Banner, Novartis Partner on Genetics-driven Trial of Alzheimer's Treatments | GenomeWeb

NEW YORK (GenomeWeb) – The Banner Alzheimer's Institute today announced a partnership with Novartis for a trial of two investigational drugs aimed at people with a particularly high risk of developing Alzheimer's at older ages.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.